Atorvastatin and carnitine combination versus atorvastatin alone impacts on the lipid profile of haemodialyzed patients: A randomised clinical trial
Open Access
- 15 December 2018
- journal article
- Published by Maad Rayan Publishing Company in Journal of Analytical Research in Clinical Medicine
- Vol. 6 (4) , 165-171
Abstract
Introduction: Dyslipidemia is one of the most common problems in hemodialysis patients and healthcare system. Some studies have suggested the use of carnitine in the treatment of dyslipidemia in hemodialysis patients. This study was carried out aiming to evaluate the effect of atorvastatin and carnitine combination versus atorvastatin alone on the lipid profile of hemodialyzed patients. Methods: In this clinical trial, 50 hemodialysis patients referred to the educational centres of Tabriz University of Medical Sciences, Tabriz, Iran, for haemodialysis were enrolled. Patients were randomly assigned into two groups. In the first group, patients were treated with carnitine (1000 mg three times daily) and atorvastatin (10-80 mg/day based on the baseline lipid profile of the patients) and in the second group, the patients were treated with atorvastatin alone for six months. The levels of triglyceride (TG), cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and haemoglobin before and after intervention were compared. The side effects of carnitine administration were also evaluated. Results: Results showed that TG, cholesterol, and LDL levels were significantly lower in the carnitine group compared to those in the other group at the end of study (P < 0.050). In addition, HDL and haemoglobin levels were significantly higher in the carnitine group in comparison to the other group (P < 0.050). No major side effects of carnitine were observed among the patients. Conclusion: The use of carnitine plus atorvastatin combination is an effective and safe method in the treatment of dyslipidemia in patients undergoing hemodialysis without imposing significant side effects.Keywords
This publication has 18 references indexed in Scilit:
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosisNature Medicine, 2013
- Dyslipidemia Associated with Chronic Kidney DiseaseThe Open Cardiovascular Medicine Journal, 2011
- Effects of l-Carnitine on Dialysis-Related Hypotension and Muscle Cramps: A Meta-analysisAmerican Journal of Kidney Diseases, 2008
- Effects of L-carnitine infusions on inflammatory and nutritional markers in haemodialysis patientsNephrology Dialysis Transplantation, 2006
- Relationship Between Serum Carnitine, Acylcarnitines, and Renal Function in Patients With Chronic Renal DiseaseJournal of Renal Nutrition, 2006
- Debate Forum: Levocarnitine Therapy Is Rational and Justified in Selected Dialysis PatientsBlood Purification, 2005
- Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality InitiativeAmerican Journal of Transplantation, 2004
- Kidney Disease as a Risk Factor for Development of Cardiovascular DiseaseHypertension, 2003
- Changing perspective of carnitine function and the need for exogenous carnitine of patients treated with hemodialysisThe American Journal of Clinical Nutrition, 1996
- Evaluation of the Effect of Intravenous L-Carnitine Therapy on Function, Structure and Fatty Acid Metabolism of Skeletal Muscle in Patients Receiving Chronic HemodialysisNephron, 1991